All these data illustrate that autophagy has a protective function against the afatinib-triggered cytotoxicity and apoptosis, and autophagy inhibition can improve the anti-cancer effect of afatinib in lung adenocarcinoma cells with activating EGFR mutations. The gene discussed is EGFR; the disease is lung adenocarcinoma.